News Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics Staff September 11, 2023 Iframe sync Post Navigation Previous XORTX Announces Participation at Upcoming Investor ConferencesNext InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 More Stories Healthcare News Pharmaceutical Relief Therapeutics Advances Publication of 2025 Half-Year Report Staff August 11, 2025 Cancer Clinical Trial Diagnostics News Patient Care Pharmaceutical HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment Staff August 11, 2025 Cancer Clinical Trial Melanoma News Pharmaceutical Vaccine IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma Staff August 10, 2025
